Position in RYTM
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$555
New position
Shares Held
5
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#293
of 299 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026MONTAG A & ASSOCIATES INC holds $1,116,311 across 17 Biotechnology names. RYTM ranks #16 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
852 | $423,213 | |
| 2 | ONC |
BeOne Medicines Ltd.
|
750 | $213,727 | |
| 3 | VKTX |
Viking Therapeutics, Inc.
|
5,013 | $195,557 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
194 | $104,168 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
137 | $85,424 | |
| 6 | CORT |
Corcept Therapeutics Inc
|
542 | $47,126 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
80 | $19,277 | |
| 8 | NKTR |
Nektar Therapeutics
|
250 | $17,452 |
All Filings in RYTM
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $555 | 5 | Shares | Sole | 2026-08-05 | |
| No filing history on record for this holder in this stock. | ||||||